Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

Published 2008 View Full Article

Authors

Keywords

Journal

LANCET NEUROLOGY

Volume 7, Issue 10, Pages 903-914

Publisher

Elsevier BV

Online

2008-09-13

DOI

10.1016/s1474-4422(08)70200-x

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

LANCET NEUROLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Ask a Question. Answer a Question.